ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Fusion Pharmaceuticals Inc

Fusion Pharmaceuticals Inc (FUSN)

21.51
0.00
( 0.00% )
Updated: 12:57:45

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
21.51
Bid
21.51
Ask
21.52
Volume
216,960
21.45 Day's Range 21.55
2.31 52 Week Range 21.58
Market Cap
Previous Close
21.51
Open
21.50
Last Trade
83
@
21.52
Last Trade Time
13:01:38
Financial Volume
$ 4,665,587
VWAP
21.5044
Average Volume (3m)
1,958,352
Shares Outstanding
68,990,263
Dividend Yield
-
PE Ratio
-15.62
Earnings Per Share (EPS)
-1.38
Revenue
2.07M
Net Profit
-94.9M

About Fusion Pharmaceuticals Inc

Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monother... Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Hamilton, Ontario, Can
Founded
1970
Fusion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FUSN. The last closing price for Fusion Pharmaceuticals was $21.51. Over the last year, Fusion Pharmaceuticals shares have traded in a share price range of $ 2.31 to $ 21.58.

Fusion Pharmaceuticals currently has 68,990,263 shares outstanding. The market capitalization of Fusion Pharmaceuticals is $1.48 billion. Fusion Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.62.

FUSN Latest News

Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer

Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer PR Newswire HAMILTON, ON...

Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates

Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates Canada NewsWire HAMILTON, ON and BOSTON, May 7, 2024 Presented interim data from TATCIST...

Kuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to Contact Law Firm

Kuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to Contact Law Firm PR Newswire NEW YORK, April 26, 2024 NEW YORK, April 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order PR Newswire HAMILTON, ON and BOSTON, April 25, 2024 HAMILTON, ON and BOSTON, April...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.10.46707146193421.4121.5521.4126322321.48715527CS
40.251.1759172154321.2621.5821.2645950821.42647229CS
129.3176.311475409812.221.589.09195835219.75073476CS
2617.41424.6341463414.121.584.1151542815.74781347CS
5217.21400.232558144.321.582.3180908114.91021592CS
15613.36163.9263803688.1521.581.9833036512.97794806CS
2603.0116.270270270318.521.581.9827350313.05997076CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MMVMultiMetaVerse Holdings Ltd
$ 1.69
(186.05%)
114.87M
GTBPGT Biopharma Inc
$ 8.2499
(164.42%)
55.15M
TANHTantech Holdings Ltd
$ 1.03
(56.77%)
59.34M
NKGNNKGen Biotech Inc
$ 1.7299
(54.46%)
29.02M
BRSHBruush Oral Care Inc
$ 0.172
(46.76%)
238.94M
MTCMMTec Inc
$ 1.3026
(-81.42%)
24.64M
CTNTCheetah Net Supply Chain Service Inc
$ 4.28
(-60.37%)
4.87M
AKTSAkoustis Technologies Inc
$ 0.1696
(-52.39%)
13.94M
VIRIVirios Therapeutics Inc
$ 0.1952
(-44.45%)
4.24M
FLJFLJ Group Limited
$ 0.8648
(-44.21%)
3.9M
CRKNCrown Electrokinetics Corporation
$ 0.1874
(9.59%)
600.7M
FFIEFaraday Future Intelligent Electric Inc
$ 1.49
(44.66%)
532.65M
GWAVGreenwave Technology Solutions Inc
$ 0.1568
(1.75%)
298.65M
BRSHBruush Oral Care Inc
$ 0.172
(46.76%)
238.94M
PEGYPineapple Energy Inc
$ 0.1438
(36.43%)
178.27M

Your Recent History

Delayed Upgrade Clock